225 related items for PubMed ID: 28079915
1. Intravenous Immunoglobulin for the Treatment of Kawasaki Disease.
Shulman ST.
Pediatr Ann; 2017 Jan 01; 46(1):e25-e28. PubMed ID: 28079915
[Abstract] [Full Text] [Related]
2. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Jan 01; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
3. Kawasaki disease: a comprehensive review of treatment options.
Patel RM, Shulman ST.
J Clin Pharm Ther; 2015 Dec 01; 40(6):620-5. PubMed ID: 26547265
[Abstract] [Full Text] [Related]
4. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 01; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
5. Advances in the treatment of Kawasaki disease.
Dominguez SR, Anderson MS.
Curr Opin Pediatr; 2013 Feb 01; 25(1):103-9. PubMed ID: 23283289
[Abstract] [Full Text] [Related]
6. Management of acute and refractory Kawasaki disease.
Tacke CE, Burgner D, Kuipers IM, Kuijpers TW.
Expert Rev Anti Infect Ther; 2012 Oct 01; 10(10):1203-15. PubMed ID: 23199405
[Abstract] [Full Text] [Related]
7. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC, Aronoff SC.
Pediatrics; 2005 Oct 01; 116(4):989-95. PubMed ID: 16199713
[Abstract] [Full Text] [Related]
8. Kawasaki Disease.
Newburger JW, Takahashi M, Burns JC.
J Am Coll Cardiol; 2016 Apr 12; 67(14):1738-49. PubMed ID: 27056781
[Abstract] [Full Text] [Related]
9. Controversies in the management of Kawasaki disease.
Lang B, Duffy CM.
Best Pract Res Clin Rheumatol; 2002 Jul 12; 16(3):427-42. PubMed ID: 12387809
[Abstract] [Full Text] [Related]
10. Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease.
Nakada T.
Pediatr Cardiol; 2015 Feb 12; 36(2):335-9. PubMed ID: 25158631
[Abstract] [Full Text] [Related]
11. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.
Dhanrajani A, Yeung RSM.
Curr Opin Rheumatol; 2017 Sep 12; 29(5):547-552. PubMed ID: 28661936
[Abstract] [Full Text] [Related]
12. Kawasaki Disease: Beyond IVIG and Aspirin.
Moussa T, Wagner-Weiner L.
Pediatr Ann; 2019 Oct 01; 48(10):e400-e405. PubMed ID: 31609999
[Abstract] [Full Text] [Related]
13. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
Zhonghua Er Ke Za Zhi; 2006 Dec 01; 44(12):891-5. PubMed ID: 17254453
[Abstract] [Full Text] [Related]
14. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease.
Zhu BH, Lv HT, Sun L, Zhang JM, Cao L, Jia HL, Yan WH, Shen YP.
Eur J Pediatr; 2012 Mar 01; 171(3):571-8. PubMed ID: 22057683
[Abstract] [Full Text] [Related]
15. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb 01; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
16. Kawasaki disease: Medical therapies.
Newburger JW.
Congenit Heart Dis; 2017 Sep 01; 12(5):641-643. PubMed ID: 28580631
[Abstract] [Full Text] [Related]
17. Update on the Management of Kawasaki Disease.
Friedman KG, Jone PN.
Pediatr Clin North Am; 2020 Oct 01; 67(5):811-819. PubMed ID: 32888683
[Abstract] [Full Text] [Related]
18. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, Iemura M, Ishii M, Kato H.
Pediatr Int; 1999 Feb 01; 41(1):1-7. PubMed ID: 10200128
[Abstract] [Full Text] [Related]
19. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
Michihata N, Matsui H, Fushimi K, Yasunaga H.
Clin Pediatr (Phila); 2015 Oct 01; 54(11):1076-80. PubMed ID: 25573948
[Abstract] [Full Text] [Related]
20. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.
J Med Assoc Thai; 2003 Aug 01; 86 Suppl 3():S656-60. PubMed ID: 14700163
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
